Brandinium

Trademark search for:

FLEASCAN

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2003-05-23 — Application filed
  • 2003-11-24 — Assigned to examiner
  • 2003-11-26 — Final disposition recorded
  • 2004-05-26 — Correspondence received in law office
  • 2004-05-28 — Paper received
  • 2004-05-28 — Sec. 1(b) claim deleted
  • 2004-05-28 — Correspondence received in law office
  • 2004-07-01 — Paper received
  • 2004-07-01 — Amendment from applicant entered
  • 2004-07-01 — Correspondence received in law office
  • 2004-07-22 — Office action issued
  • 2004-12-20 — Paper received
  • 2004-12-20 — Divisional request received
  • 2005-01-07 — Exparte appeal received at ttab
  • 2005-01-25 — Ex parte appeal-instituted
  • 2005-02-04 — Divisional processing complete
  • 2005-05-25 — Approved for pub - principal register
  • 2005-05-27 — Assigned to lie
  • 2005-06-06 — Law office publication review completed
  • 2005-08-31 — Notice of publication
  • 2005-09-20 — Published for opposition
  • 2005-12-13 — Registered-principal register
  • 2012-09-21 — Cancelled sec. 8 (6-yr)
  • 2012-09-21 — Final status recorded

Owner Information

NEUFELD, KLAUS DDR.
Heiligenkreuz AT
NEUFELD, KLAUS DDR.
Heiligenkreuz AT
NEUFELD, KLAUS DDR.
Heiligenkreuz AT

Correspondent

HERBERT DUBNO KARL F ROSS PC
5676 RIVERDALE AVE STE 310
BRONX (RIVERDALE), NY 10471-0900
UNITED STATES

Filing Details

Filing Date:
2003-05-23
Status Date:
2012-09-21
Category:
Pharmaceuticals
Filing Year:
2003

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.